IL33 and asthma: Different advanced approaches, such as the use of anti-ST2 antibody (clone E310) [55, 56], anti-IL-33 antibody [57], or soluble ST2-Fc fusion protein [53] have been used to investigate the role of the ST2/IL-33 pathway in asthma models.